JWM
HZNP

Janiczek Wealth Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Janiczek Wealth Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-42
Closed -$4.86K – 1187
2023
Q3 		$4.86K Hold
42
– – ﹤0.01% 727
2023
Q2 		$4.32K Hold
42
– – ﹤0.01% 678
2023
Q1 		$4.69K Hold
42
– – ﹤0.01% 671
2022
Q4 		$4.75K Hold
42
– – ﹤0.01% 658
2022
Q3 		$3K Sell
42
-35
-45% -$2.45K ﹤0.01% 741
2022
Q2 		$6K Sell
77
-94
-55% -$8.9K ﹤0.01% 655
2022
Q1 		$18K Sell
171
-69
-29% -$6.72K 0.01% 480
2021
Q4 		$26K Buy
240
+8
+3% +$873 0.01% 443
2021
Q3 		$25K Buy
232
+26
+13% +$2.7K 0.01% 415
2021
Q2 		$19K Buy
206
+56
+37% +$5.15K 0.01% 446
2021
Q1 		$14K Buy
150
+86
+134% +$7.26K 0.01% 471
2020
Q4 		$5K Buy
64
+58
+967% +$4.31K ﹤0.01% 609
2020
Q3 		$0 Buy
+6
New +$413 ﹤0.01% 749

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Janiczek Wealth Management's HZNP Position: Q4 2023 in Review

Janiczek Wealth Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 42 shares — an estimated $4.86K sold.

Janiczek Wealth Management first reported a position in HZNP in Q3 2020 and held it in 13 quarters. The position peaked at $26K in Q4 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Janiczek Wealth Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Janiczek Wealth Management sold 42 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $4.86K.
  • Janiczek Wealth Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and held it in 13 quarters.
  • Janiczek Wealth Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $26K in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Janiczek Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.